US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Blue Ribbon Income Fund (PK) (BLUBF) 銘柄情報

Blue Ribbon Income Fund (PK) (BLUBF)

6.0611

0.00

(0.00%)

終了 7月10日 5:00AM

Blue Ribbon Income Fund (PK) (BLUBF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

6.0611

( - )

買値

6.0611

売値

6.0611

出来高

-

平均取引量 (3 か月)

US$ 4,553

財務取引量

-

0.00 日の範囲 0.00

5.51 52 週間の範囲 6.0611

時価総額

企業価値

56.836M

前日終値

6.0611

始値

-

時刻

最終取引時間

VWAP

-

歳入

5.22M

純利益

4.26M

発行済株式数

6,636,258

浮動株比率 (%)

-

機関投資家保有比率 (%)

-

配当利回り

0.48 (5.81%)

PER

15.18

株価売上高倍率 (PSR)

11.11

1 株当たり利益 (EPS)

0.58

ベータ

0.7

Blue Ribbon Income Fund is a closed-ended equity mutual fund launched and managed by Bloom Investment Counsel, Inc. The fund invests in public equity markets of Canada. It benchmarks the performance of its portfolio against the S&P/TSX Income Trust Index. The fund was formerly known as the Citadel D... Blue Ribbon Income Fund is a closed-ended equity mutual fund launched and managed by Bloom Investment Counsel, Inc. The fund invests in public equity markets of Canada. It benchmarks the performance of its portfolio against the S&P/TSX Income Trust Index. The fund was formerly known as the Citadel Diversified Investment Trust. Blue Ribbon Income Fund was formed on September 16, 1997 and is domiciled in Canada. 詳細を表示

セクター

Finance

業界

Asset Management Services

ウェブサイト

www.bromptongroup.com

本社

Toronto, Canada

設立

1997

Blue Ribbon Income Fund (PK) is listed in the Finance sector of the その他OTC with ticker BLUBF. The last closing price for Blue Ribbon Income (PK) was US$6.06. Over the last year, Blue Ribbon Income (PK) shares have traded in a share price range of US$ 5.51 to US$ 6.0611.

Blue Ribbon Income (PK) currently has 6,636,258 shares in issue. The market capitalisation of Blue Ribbon Income (PK) is US$40.22 million. Blue Ribbon Income (PK) has a price to earnings ratio (PE ratio) of 15.18.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	6.0611	6.0611	6.0611	0	0	CS
26	0	0	6.0611	6.0611	6.0611	0	0	CS
52	0.4811	8.62186379928	5.58	6.0611	5.51	66	5.87380435	CS
156	0.4611	8.23392857143	5.6	6.0611	5.51	75	5.8082265	CS
260	-0.829269	-12.0351899876	6.890369	7	5.4	1192	6.27148675	CS

BLUBF - Frequently Asked Questions (FAQ)

What is the current Blue Ribbon Income Fund (PK) share price?

The current share price of Blue Ribbon Income Fund (PK) is US$ 6.0611

How many Blue Ribbon Income Fund (PK) shares are in issue?

Blue Ribbon Income Fund (PK) has 6,636,258 shares in issue

What is the market cap of Blue Ribbon Income Fund (PK)?

The market capitalisation of Blue Ribbon Income Fund (PK) is USD 40.22M

What is the 1 year trading range for Blue Ribbon Income Fund (PK) share price?

Blue Ribbon Income Fund (PK) has traded in the range of US$ 5.51 to US$ 6.0611 during the past year

What is the PE ratio of Blue Ribbon Income Fund (PK)?

The price to earnings ratio of Blue Ribbon Income Fund (PK) is 15.18

What is the cash to sales ratio of Blue Ribbon Income Fund (PK)?

The cash to sales ratio of Blue Ribbon Income Fund (PK) is 11.11

What is the registered address of Blue Ribbon Income Fund (PK)?

The registered address for Blue Ribbon Income Fund (PK) is 150 York Street, Toronto, Ontario, M5H 3S5

What is the Blue Ribbon Income Fund (PK) website address?

The website address for Blue Ribbon Income Fund (PK) is www.bromptongroup.com/funds/fund/rbn/overview

Which industry sector does Blue Ribbon Income Fund (PK) operate in?

Blue Ribbon Income Fund (PK) operates in the Asset Management Services sector

Ranb2khz

Ranb2khz 11分前

Save The Psuche

“Therefore, putting aside all filthiness and all that remains of wickedness, in humility receive the word implanted, which is able to save your souls.” ~ James 1:21

The word translated “souls” in this verse is the Greek word “psuche.” Psuche is where we

StarryComet61

StarryComet61 12分前

I am hesitant to buy this one because of what happened to $TWSI ,.why do you guys think this one could be different?

US Market News

US Market News 13分前

Yum China to Report Second Quarter 2026 Financial ResultsJuly 10, 2026 5:00 AM
PR Newswire (US) class="legendSpanClass"SHANGHAI, class="legendSpanClass"July 10, 2026 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, "Y

fuagf

Day 2, Matt F is -5 after 6, par #1 then 5 birdies has to have him
a bit Pop-eyed, i'm wondering what kind of spinach he's on.

MusicExec

MusicExec 19分前

You only need to look at the published financial data and extrapolate the cash flow numbers to understand how little of this $1 B in historically accrued revenues has actually been collected as cash !
Clue : it is not a big number !
Instead of blind optimism you should also read the

TradingStocks

TradingStocks 23分前

Forget my last post on July 7th. I thought this was moving up but it's not doing that just yet.

GoodGuyBill

GoodGuyBill 25分前

But there is no indication that NWBO submitted a BLA to the FDA. NWBO did, however, submit a MAA the MHRA.
The article should have focused on the MHRA submission and is a complete lack of due diligence.

Sideem

Sideem 26分前

I wound up getting the BBUL quote on Yahoo Finance. But I searched BBUL this morning on IHub and the quote page loaded fine.

Lsmith500

Lsmith500 29分前

Follow $SNTX official page on X for huge announcements!!
https://x.com/suntexcorp?s=21

threewheeler

threewheeler 60分前

07/10/2026 OTCID Market LogoGEAT GreetEat Corporation Pink Limited OTCID Common Stock

alm2

alm2 1時間前

Mochida sales of Epadel EM
Chat digging further -
Epadel EM is now 48per cent of their Epadel sales
Epadel EM is now number one selling drug EOA drug in Japan !!!!
There appears to be therefore a step change in acceptance of this new formulation delivery in Japan

rakp

rakp 1時間前

Thanks BB for the update

pgsd

pgsd 1時間前

Peter Davis
@peter_brit
#dcvax $nwbo #gbm

931 Days Later: Why the FDA Delay on Northwest Biotherapeutics' DCVax Scares Global Markets

A 931-day FDA delay on Northwest Biotherapeutics' glioblastoma vaccine DCVax-L threatens independent biotech and denies t

Nemesis18

Nemesis18 1時間前

I 100% agree. Its a binary outcome now. If DCVAX-L is not approved, then NWBO is finished. It's game over. Your shares will become worthless.

Which is horrendous for you guys, but a perfect out for LP into retirement. Over her 20+ year Executive Governance, she has shown zero regard

alm2

alm2 1時間前

Mochida sales all Epadel -in dollars
24-45.8m
25-29.7
26-28.4
27-32.8 predicted
They have generic competition
Alm

US Market News

US Market News 1時間前

U.K. Firms Make Cyber Resilience MeasurableJuly 10, 2026 4:00 AM
Business Wire Boards and regulators push enterprises to prove response readiness and operational impact as AI-enabled threats grow, ISG Provider Lens® report says Enterprises in

alm2

alm2 2時間前

Mochida-Epadel EM -once a day formulation
Conventional V is two capsules twice daily so four capsules
Launched by Mochida sept 2022 in Japan Epadel EM uses a self emulsifying formulation to improve absorption and thus reduced to one 2g capsule a day
Post marketing surveillanc

Kam8

Kam8 2時間前

Hello.

Hello

Hello

Can'tSparTheGhost

Can'tSparTheGhost 2時間前

High pulse today✈️

$DPLS

CA Market News

CA Market News 2時間前

Quest Critical Metals Announces Management ChangesJuly 10, 2026 3:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - July 10,

Investor2014

Investor2014 2時間前

You may be right, the problem though is that 90% of your posts are what appears as deliberate and intentional lies.

US Market News

US Market News 2時間前

Morgan Stanley Infrastructure Partners Enters Into Agreement to Acquire Majority Stake in Nicollin EnvironnementJuly 10, 2026 3:05 AM
Business Wire Morgan Stanley Investment Management (MSIM), through investment funds managed by Morgan Stanley Infrastructure Partners (MSIP), it

Blue Ribbon Income (PK)

CRSP US Small Mid Cap OSV

Nts Lkd Uksed3p Pref Shs...

Lockheed Martin

MMK vs Sterling

First Trust Skybridge Cr...

Cognyte Software

Ecofin US Renewables Inf...

Medical Properties

2.25% 21may2028

Powermax Minerals

Invesco Markets Ii

Nuveen Global Net Zero E...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。